<DOC>
	<DOCNO>NCT00778531</DOCNO>
	<brief_summary>The purpose post-approval study evaluate continue safety ArteFill injectable implant correction nasolabial fold course five year post implantation , focus determine incidence granuloma formation . Incidence adverse event subject satisfaction respect subject 's personal expectation assess .</brief_summary>
	<brief_title>Protocol Post-approval Study ArteFillÂ® Correction Nasolabial Folds</brief_title>
	<detailed_description>This study multi-center , non-randomized , non-controlled post-approval study design follow total 1000 consecutive qualify consent subject treat ArteFill course clinical practice approximately twenty-five center . All potential qualifying subject give site give opportunity participate study . Inclusion exclusion criterion limit approve label ArteFill treatment accord approve product labeling . Subjects must previously document negative skin test prior treatment .</detailed_description>
	<mesh_term>Polymethyl Methacrylate</mesh_term>
	<criteria>Subject male nonpregnant female 18 year age old . Subject provide write verbal informed consent . Subject willing comply study instruction return clinic require visit . Subject willing withhold additional aesthetic implant therapy NLF [ e.g. , soft tissue filler : Restylane , Silicone , Radiesse , Sculptra ) implant : gortex , silastic , thread lift , etc . ] duration study . Subject skin pathology condition could interfere evaluation treatment area . Subject history systemic granulomatous disease active inactive ( e.g.Sarcoid , Wegeners , TB , etc . ) connective tissue disease ( .e.g. , lupus , dermatomyositis , etc. ) . Subject immunocompromised opinion investigator disease medical therapy ( e.g. , HIV , use chemotherapy , etc . ) Subject treat follow NLF time interval specify prior start participation study : Bovine collagen 6 month Porcine human collagen one year Hyaluronic acid one year Hydroxylapatite one year Autologous fat time Polymethylmethacrylate acrylate time Polyacrylamide time Polyethylene oxide time Polylactic acid time Liquid silicone time Other permanent implant material ( FDA approve ) time Subject placement surgical implant NL fold region ( e.g. , Gortex , Silastic implant , thread lift , etc . ) time . Subject history multiple severe allergy allergy manifest anaphylaxis . Subject history allergy lidocaine . Subject history allergy bovine collagen product , include limited injectable collagen , collagen implant , hemostatic sponge , collagenbased suture . The subject know hypersensitivity previous allergic reaction component study device previously mention . Subject undergo planning undergo desensitization injection meat product . Subject condition , Investigator 's opinion , would make unsafe subject participate research study . Subject unable communicate cooperate Investigator due language problem , poor mental development , impaired cerebral function . Subject may unreliable study include subject engage excessive alcohol intake drug abuse , subject unable return schedule followup visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>injectable implant</keyword>
	<keyword>nasolabial fold</keyword>
	<keyword>Correction nasolabial fold</keyword>
</DOC>